Stratifin accelerates progression of lung adenocarcinoma at an early stage

Molecular Cancer

Volumn 14, Issue 1, 2015, Pages

  Shiba Ishii, Aya ^a   Kim, Yunjung ^a   Shiozawa, Toshihiro ^a   Iyama, Shinji ^a   Satomi, Kaishi ^a   Kano, Junko ^a   Sakashita, Shingo ^a   Morishita, Yukio ^b   Noguchi, Masayuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Lung adenocarcinoma; Malignant progression; NNK; Stratifin; Tg SPC SFN+

Indexed keywords

STRATIFIN; 4-(N-METHYL-N-NITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; EXORIBONUCLEASE; NITROSAMINE; PROTEIN 14 3 3; SFN PROTEIN, HUMAN; TUMOR MARKER;

A549 CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER STAGING; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; TRANSGENIC MOUSE; ADENOCARCINOMA; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED; DISEASE EXACERBATION; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METASTASIS; PATHOLOGY; TUMOR CELL LINE;

14-3-3 PROTEINS; ADENOCARCINOMA; ADENOCARCINOMA OF LUNG; ANIMALS; BIOMARKERS, TUMOR; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; EXORIBONUCLEASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; NEOPLASM STAGING; NITROSAMINES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84989247278     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/s12943-015-0414-1     Document Type: Article

References (16)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer. 1995;75:2844-52.
3. Yim J, Zhu LC, Chiriboga L, Watson HN, Goldberg JD, Moreira AL. Histologic features are important prognostic indicators in early stages lung adenocarcinomas. Mod Pathol. 2007;20:233-41.
4. Shiba-Ishii A, Kano J, Morishita Y, Sato Y, Minami Y, Noguchi M. High expression of stratifin is a universal abnormality during the course of malignant progression of early-stage lung adenocarcinoma. Int J Cancer. 2011;129:2445-53.
5. Shiba-Ishii A, Noguchi M. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma. Am J Pathol. 2012;180:1653-62.
6. Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, et al. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell. 1997;1:3-11.
7. Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature. 1999;401:616-20.
8. Samuel T, Weber HO, Rauch P, Verdoodt B, Eppel JT, McShea A, et al. The G2/M regulator 14-3-3sigma prevents apoptosis through sequestration of Bax. J Biol Chem. 2001;276:45201-6.
9. Subramanian RR, Masters SC, Zhang H, Fu H. Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis. Exp Cell Res. 2001;271:142-51.
10. Mase K, Iijima T, Nakamura N, Takeuchi T, Onizuka M, Mitsui T, et al. Intrabronchial orthotopic propagation of human lung adenocarcinoma-characterizations of tumorigenicity, invasion and metastasis. Lung Cancer. 2002;36:271-6.
11. Akopyan G, Bonavida B. Understanding tobacco smoke carcinogen NNK and lung tumorigenesis. Int J Oncol. 2006;29:745-52.
12. Soda M, Takada S, Takeuchi K, Choi YL, Enomoto M, Ueno T, et al. A mouse model for EML4-ALK-positive lung cancer. Proc Natl Acad Sci U S A. 2008;105:19893-7.
13. Mitsudomi T, Yatabe Y. Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer. Cancer Sci. 2007;98:1817-24.
14. Cancer Genome Atlas Research N. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511:543-50.
15. Noguchi M. Stepwise progression of pulmonary adenocarcinoma-clinical and molecular implications. Cancer Metastasis Rev. 2010;29:15-21.
16. Huang Y, Yang X, Zhao F, Shen Q, Wang Z, Lv X, et al. Overexpression of Dickkopf-1 predicts poor prognosis for patients with hepatocellular carcinoma after orthotopic liver transplantation by promoting cancer metastasis and recurrence. Med Oncol. 2014;31:966.